首页> 美国卫生研究院文献>Cancer Science >Semi‐quantitative Analysis of DNA Topoisomerase‐I mRNA Level Using Reverse Transcription‐Polymerase Chain Reaction in Cancer Cell Lines: Its Relation to Cytotoxicity against Camptothecin Derivative
【2h】

Semi‐quantitative Analysis of DNA Topoisomerase‐I mRNA Level Using Reverse Transcription‐Polymerase Chain Reaction in Cancer Cell Lines: Its Relation to Cytotoxicity against Camptothecin Derivative

机译:使用逆转录-聚合酶链反应在癌细胞系中对DNA拓扑异构酶-I mRNA水平进行半定量分析:与喜树碱衍生物对细胞毒性的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Expression of DNA topoisomerase (Topo)‐I mRNA in various cancer cell lines was detected using the reverse transcription‐polymerase chain reaction (RT‐PCR) method. The cytoplasmic polyadenylated RNA isolated from cancer cell lines was reverse‐transcribed and the complementary DNA was amplified by PCR primed with Topo‐I specific primers. Fidelity of the amplified sequence was confirmed by restriction endonuclease digestion and Southern blot hybridization. The level of Topo‐I mRNA was correlated positively with the cytotoxicity of a Topo‐I inhibitor, a camptothecin derivative. This RT‐PCR method may be applicable to the assessment of sensitivity of cells to Topo‐I targeted drugs, especially when only small quantities of cell samples are available.
机译:使用逆转录聚合酶链反应(RT-PCR)方法检测了各种癌细胞系中的DNA拓扑异构酶(Topo)-I mRNA表达。从癌细胞系中分离出的胞质聚腺苷酸RNA进行逆转录,并通过用Topo-I特异引物进行PCR扩增互补DNA。通过限制性核酸内切酶消化和Southern印迹杂交证实了扩增序列的保真度。 Topo-I mRNA的水平与Topo-I抑制剂(喜树碱衍生物)的细胞毒性呈正相关。这种RT‐PCR方法可能适用于评估细胞对Topo‐I靶向药物的敏感性,尤其是在只有少量细胞样品的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号